Sleep-specific DBS Therapy in Parkinson's Disease
RecruitingNCT05962489Phase: NAStarted 2023-06-22
Summary
Sleep-wake disturbances are a major factor associated with reduced quality of life of individuals with Parkinson's disease (PD), a progressive neurological disorder affecting millions of people in the
Eligibility
Sex
ALL
Min Age
21 Years
Max Age
None
Locations
University Of MinnesotaMinneapolis, Minnesota, United States
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT05962489